Recently, the regulatory role of RNA m5C on HCC progression has been uncovered, and evidence has indicated that the elevated m5C regulators NSUN4 and ALYREF are negatively correlated with poor survival outcome in HCC patients and exhibit great value as significant diagnostic and prognostic biomarkers for HCC [24]. The gene discussed is ALYREF; the disease is hepatocellular carcinoma.